These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33660918)

  • 21. Evidence to Avoid Overtesting and Overuse in Diabetes Mellitus and Other Diseases.
    Barry K; Slawson DC; Shaughnessy AF
    Am Fam Physician; 2020 Nov; 102(10):583-584. PubMed ID: 33179893
    [No Abstract]   [Full Text] [Related]  

  • 22. [Monitoring of the insulin treated diabetic].
    Soltani D; Perlemuter L
    Presse Med; 1998 Jul 4-11; 27(24):1251-4. PubMed ID: 9767789
    [No Abstract]   [Full Text] [Related]  

  • 23. [Insulin aspart].
    Namba M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():492-7. PubMed ID: 12387040
    [No Abstract]   [Full Text] [Related]  

  • 24. Visualization of Blood Glucose Fluctuations Using Continuous Glucose Monitoring in Patients Undergoing Hemodialysis.
    Mori K; Emoto M; Abe M; Inaba M
    J Diabetes Sci Technol; 2019 Mar; 13(2):413-414. PubMed ID: 30580579
    [No Abstract]   [Full Text] [Related]  

  • 25. [Inhaled insulin].
    Uchigata Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():534-41. PubMed ID: 12387047
    [No Abstract]   [Full Text] [Related]  

  • 26. The gluco-phenotype.
    Kalra S; Gupta Y
    J Pak Med Assoc; 2016 Jan; 66(1):118-9. PubMed ID: 26712197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of glycemic control in diabetes in the CVOT era.
    Einhorn D
    J Diabetes; 2020 Jan; 12(1):4. PubMed ID: 31746129
    [No Abstract]   [Full Text] [Related]  

  • 28. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
    Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
    Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Will the use of insulin analogs improve glycemic control during adolescence?
    Dunger DB
    Pediatr Diabetes; 2003 Jun; 4(2):61-3. PubMed ID: 14655260
    [No Abstract]   [Full Text] [Related]  

  • 30. Remote Glucose Monitoring Platform for Multiple Simultaneous Patients at Coronavirus Disease 2019 Intensive Care Units: Case Report Including Adults and Children.
    Garelli F; Rosales N; Fushimi E; Arambarri D; Mendoza L; De Battista H; Sánchez-Peña R; García Arabehety J; Distefano S; Barcala C; Giunta J; Las Heras M; Martinez Mateu C; Prieto M; San Román E; Krochik G; Grosembacher L
    Diabetes Technol Ther; 2021 Jun; 23(6):471-473. PubMed ID: 33337261
    [No Abstract]   [Full Text] [Related]  

  • 31. Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19.
    Pasquel FJ; Messler J; Booth R; Kubacka B; Mumpower A; Umpierrez G; Aloi J
    JAMA Netw Open; 2021 Mar; 4(3):e211091. PubMed ID: 33688962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia in insulin-dependent diabetic patients.
    Darling JD; O'Donnell TFX; Deery SE; Norman AV; Vu GH; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2018 Nov; 68(5):1455-1464.e1. PubMed ID: 30360841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of hemoglobin A1C level with surgical outcomes: Can tight perioperative glucose control reduce infection and cardiac events?
    Shaw P; Saleem T; Gahtan V
    Semin Vasc Surg; 2014 Dec; 27(3-4):156-61. PubMed ID: 26073825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of diabetes in elderly patients during the COVID-19 pandemic: current and future perspectives.
    Rajpal A; Sayyed Kassem L; Aron DC
    Expert Rev Endocrinol Metab; 2021 Jul; 16(4):181-189. PubMed ID: 34096441
    [No Abstract]   [Full Text] [Related]  

  • 35. Regular mailing of personalized feedback reports improves glycemic control in diabetes: A randomized controlled trial.
    Yin J; Luk A; Wong R; Chung H; Kong A; Ozaki R; Ma R; Chow CC; So W; Chan J
    J Diabetes; 2017 May; 9(5):536-538. PubMed ID: 28083979
    [No Abstract]   [Full Text] [Related]  

  • 36. Some young adults with cystic fibrosis-related diabetes may safely stop insulin without any adverse clinical sequelae.
    Ogbolu C; Arregui-Fresneda I; Daniels T; Holt RIG
    Diabet Med; 2020 Jul; 37(7):1205-1208. PubMed ID: 32115764
    [No Abstract]   [Full Text] [Related]  

  • 37. Non-enzymatic glycosylation of serum proteins as an indicator of diabetic control.
    Gragnoli G; Tanganelli I; Signorini AM; Tarli P; Paoli C
    Acta Diabetol Lat; 1982; 19(2):161-6. PubMed ID: 7051713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of glycaemic control in patients with diabetes mellitus on insulin therapy.
    Mukherjee JJ; Majumdar S; Ray S
    J Indian Med Assoc; 2013 Nov; 111(11):761-5. PubMed ID: 24968486
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current methods of glucose metabolism control in diabetes mellitus].
    Scarpitta AM; Sinagra D
    Recenti Prog Med; 2003 Jan; 94(1):31-40. PubMed ID: 12632998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin for intensifying diabetes treatment.
    Meneghini LF
    J Fam Pract; 2011 Sep; 60(9 Suppl):S21-8. PubMed ID: 21912774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.